The findings draw on responses from more than 11,500 households, and the research marks the third year Worldpanel has studied Britain\u2019s relationship with weight loss drugs.<\/p>\n
Grocery spend by user households has declined by \u00a3780m, with 299 million fewer packs\u00a0purchased\u00a0across the analysis period in total. This equates to\u00a0a\u00a0\u00a3418 decline in per household spend when compared to non-user households.<\/p>\n
Over half of users (54%) report experiencing fewer cravings and less \u2018food noise\u2019, with one in ten (11%) no longer enjoying their usual food and drink favourites.<\/p>\n
While users say they are cutting back, 75% on chocolate and 72% on crisps, their shopping habits tell the same story.<\/p>\n
Since starting GLP-1 treatments, chocolate confectionery spend among users has fallen 18 percentage points more than in non-user households.<\/p>\n
However, not all categories are losing out. GLP-1 users are navigating side effects through more considered purchasing, creating measurable uplifts in specific areas.<\/p>\n
\u2018Ozempic mouth\u2019 \u2013 the common side effect of dry mouth and bad breath \u2013 is driving a\u00a020 percentage\u00a0point uplift in mouthwash\u00a0spend\u00a0and a\u00a024 percentage\u00a0point uplift in chewing gum confectionery\u00a0spend\u00a0among GLP-1 user households compared to non-user households.<\/p>\n
The findings also reveal that over half (52%) of users now describe their approach to eating as mindful, meaning they are guided by their body\u2019s hunger cues rather than habit,\u00a0routine\u00a0or restriction.<\/p>\n
Similarly, users\u2019 expectations of food businesses and retailers are changing. Retailers and\u00a0manufacturers\u2019 ability to respond to these users\u2019\u00a0new needs will be key to staying relevant with them in the future.<\/p>\n
Chantel Kennaugh, head of public sector and nutrition, GB for Worldpanel by Numerator said: \u201cWhat was once a specialised treatment, primarily prescribed for type 2 diabetes, has in just a few short years become a mainstream force. Now, 68% of users are taking GLP-1s specifically to lose weight, opening them up to a much wider audience.<\/p>\n
\u201cThese drugs are fundamentally disrupting how people engage with food and drink, with ripple effects already being felt across grocery and lifestyle, forcing brands and businesses to adapt at pace.\u201d<\/p>\n
Nishita Pattni, senior consultant at Worldpanel by Numerator concluded:\u00a0\u201cThe picture ahead is complex. While 72% believe GLP-1 medications are being adopted too quickly without sufficient understanding of their long-term effects, growth shows no sign of slowing.<\/p>\n
\u201cRising adoption in markets like the US, combined with continued innovation, points to even faster uptake. As these drugs reshape user needs, consumers will increasingly look to retailers and manufacturers for support and guidance.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"The findings draw on responses from more than 11,500 households, and the research marks the third year Worldpanel…\n","protected":false},"author":2,"featured_media":60017,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[2],"tags":[13,11694,25235],"class_list":["post-60016","post","type-post","status-publish","format-standard","has-post-thumbnail","category-britain","tag-britain","tag-glp-1","tag-kantar-worldpanel"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@UnitedKingdom\/116725733366719041","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/posts\/60016","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/comments?post=60016"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/posts\/60016\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/media\/60017"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/media?parent=60016"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/categories?post=60016"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/tags?post=60016"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}